#Cost-analysis of virtual reality training based on the Virtual Reality for Upper Extremity in Subacute stroke (VIRTUES) trial
1	1	0	13	Cost-analysis
1	2	14	16	of
1	3	17	24	virtual
1	4	25	32	reality
1	5	33	41	training
1	6	42	47	based
1	7	48	50	on
1	8	51	54	the
1	9	55	62	Virtual
1	10	63	70	Reality
1	11	71	74	for
1	12	75	80	Upper
1	13	81	90	Extremity
1	14	91	93	in
1	15	94	102	Subacute
1	16	103	109	stroke
1	17	110	111	(
1	18	111	118	VIRTUES
1	19	118	119	)
1	20	120	125	trial
#OBJECTIVES: Stroke is a major cause of lasting disability worldwide.
2	1	126	136	OBJECTIVES
2	2	136	137	:
2	3	138	144	Stroke
2	4	145	147	is
2	5	148	149	a
2	6	150	155	major
2	7	156	161	cause
2	8	162	164	of
2	9	165	172	lasting
2	10	173	183	disability
2	11	184	193	worldwide
2	12	193	194	.
#Virtual reality (VR) training has been introduced as a means of increasing the effectiveness of rehabilitation by providing large doses of task-related training with many repetitions and different modes of feedback.
3	1	264	271	Virtual
3	2	272	279	reality
3	3	280	281	(
3	4	281	283	VR
3	5	283	284	)
3	6	285	293	training
3	7	294	297	has
3	8	298	302	been
3	9	303	313	introduced
3	10	314	316	as
3	11	317	318	a
3	12	319	324	means
3	13	325	327	of
3	14	328	338	increasing
3	15	339	342	the
3	16	343	356	effectiveness
3	17	357	359	of
3	18	360	374	rehabilitation
3	19	375	377	by
3	20	378	387	providing
3	21	388	393	large
3	22	394	399	doses
3	23	400	402	of
3	24	403	415	task-related
3	25	416	424	training
3	26	425	429	with
3	27	430	434	many
3	28	435	446	repetitions
3	29	447	450	and
3	30	451	460	different
3	31	461	466	modes
3	32	467	469	of
3	33	470	478	feedback
3	34	478	479	.
#As VR is increasingly used in neurorehabilitation, cost considerations are important.
4	1	696	698	As
4	2	699	701	VR
4	3	702	704	is
4	4	705	717	increasingly
4	5	718	722	used
4	6	723	725	in
4	7	726	745	neurorehabilitation
4	8	745	746	,
4	9	747	751	cost
4	10	752	766	considerations
4	11	767	770	are
4	12	771	780	important
4	13	780	781	.
#METHODS: A cost-analysis was conducted based on the Virtual Reality for Upper Extremity in Subacute stroke (VIRTUES) trial, a recent international randomized controlled observer-blind multicenter trial.
5	1	868	875	METHODS
5	2	875	876	:
5	3	877	878	A
5	4	879	892	cost-analysis
5	5	893	896	was
5	6	897	906	conducted
5	7	907	912	based
5	8	913	915	on
5	9	916	919	the
5	10	920	927	Virtual
5	11	928	935	Reality
5	12	936	939	for
5	13	940	945	Upper
5	14	946	955	Extremity
5	15	956	958	in
5	16	959	967	Subacute
5	17	968	974	stroke
5	18	975	976	(
5	19	976	983	VIRTUES
5	20	983	984	)
5	21	985	990	trial
5	22	990	991	,
5	23	992	993	a
5	24	994	1000	recent
5	25	1001	1014	international
5	26	1015	1025	randomized
5	27	1026	1036	controlled
5	28	1037	1051	observer-blind
5	29	1052	1063	multicenter
5	30	1064	1069	trial
5	31	1069	1070	.
#Average therapist time required per therapy session may differ between VR and conventional training (CT), leading to potential cost savings due to a therapist being able to supervise more than one patient at a time.
6	1	1274	1281	Average
6	2	1282	1291	therapist
6	3	1292	1296	time
6	4	1297	1305	required
6	5	1306	1309	per
6	6	1310	1317	therapy
6	7	1318	1325	session
6	8	1326	1329	may
6	9	1330	1336	differ
6	10	1337	1344	between
6	11	1345	1347	VR
6	12	1348	1351	and
6	13	1352	1364	conventional
6	14	1365	1373	training
6	15	1374	1375	(
6	16	1375	1377	CT
6	17	1377	1378	)
6	18	1378	1379	,
6	19	1380	1387	leading
6	20	1388	1390	to
6	21	1391	1400	potential
6	22	1401	1405	cost
6	23	1406	1413	savings
6	24	1414	1417	due
6	25	1418	1420	to
6	26	1421	1422	a
6	27	1423	1432	therapist
6	28	1433	1438	being
6	29	1439	1443	able
6	30	1444	1446	to
6	31	1447	1456	supervise
6	32	1457	1461	more
6	33	1462	1466	than
6	34	1467	1470	one
6	35	1471	1478	patient
6	36	1479	1481	at
6	37	1482	1483	a
6	38	1484	1488	time
6	39	1488	1489	.
#Exploratory cost analyses are presented to explore such assumptions.
7	1	1706	1717	Exploratory
7	2	1718	1722	cost
7	3	1723	1731	analyses
7	4	1732	1735	are
7	5	1736	1745	presented
7	6	1746	1748	to
7	7	1749	1756	explore
7	8	1757	1761	such
7	9	1762	1773	assumptions
7	10	1773	1774	.
#RESULTS: Based on our calculations, VR incurs extra costs as compared with CT when the same amount of therapist contact is provided, as was the case in VIRTUES.
8	1	1844	1851	RESULTS
8	2	1851	1852	:
8	3	1853	1858	Based
8	4	1859	1861	on
8	5	1862	1865	our
8	6	1866	1878	calculations
8	7	1878	1879	,
8	8	1880	1882	VR
8	9	1883	1889	incurs
8	10	1890	1895	extra
8	11	1896	1901	costs
8	12	1902	1904	as
8	13	1905	1913	compared
8	14	1914	1918	with
8	15	1919	1921	CT
8	16	1922	1926	when
8	17	1927	1930	the
8	18	1931	1935	same
8	19	1936	1942	amount
8	20	1943	1945	of
8	21	1946	1955	therapist
8	22	1956	1963	contact
8	23	1964	1966	is
8	24	1967	1975	provided
8	25	1975	1976	,
8	26	1977	1979	as
8	27	1980	1983	was
8	28	1984	1987	the
8	29	1988	1992	case
8	30	1993	1995	in
8	31	1996	2003	VIRTUES
8	32	2003	2004	.
#However, the exploratory analyses demonstrated that these costs may be rapidly counterbalanced when time for therapist supervision can be reduced.
9	1	2166	2173	However
9	2	2173	2174	,
9	3	2175	2178	the
9	4	2179	2190	exploratory
9	5	2191	2199	analyses
9	6	2200	2212	demonstrated
9	7	2213	2217	that
9	8	2218	2223	these
9	9	2224	2229	costs
9	10	2230	2233	may
9	11	2234	2236	be
9	12	2237	2244	rapidly
9	13	2245	2260	counterbalanced
9	14	2261	2265	when
9	15	2266	2270	time
9	16	2271	2274	for
9	17	2275	2284	therapist
9	18	2285	2296	supervision
9	19	2297	2300	can
9	20	2301	2303	be
9	21	2304	2311	reduced
9	22	2311	2312	.
#CONCLUSIONS: Extra costs for VR can be outweighed by reduced therapist time and decreasing VR system costs in the nearer future, and not least by increased patient motivation.
10	1	2460	2471	CONCLUSIONS
10	2	2471	2472	:
10	3	2473	2478	Extra
10	4	2479	2484	costs
10	5	2485	2488	for
10	6	2489	2491	VR
10	7	2492	2495	can
10	8	2496	2498	be
10	9	2499	2509	outweighed
10	10	2510	2512	by
10	11	2513	2520	reduced
10	12	2521	2530	therapist
10	13	2531	2535	time
10	14	2536	2539	and
10	15	2540	2550	decreasing
10	16	2551	2553	VR
10	17	2554	2560	system
10	18	2561	2566	costs
10	19	2567	2569	in
10	20	2570	2573	the
10	21	2574	2580	nearer
10	22	2581	2587	future
10	23	2587	2588	,
10	24	2589	2592	and
10	25	2593	2596	not
10	26	2597	2602	least
10	27	2603	2605	by
10	28	2606	2615	increased
10	29	2616	2623	patient
10	30	2624	2634	motivation
10	31	2634	2635	.
